Print

Aastrom Biosciences, Inc. (ASTM) to Host First Quarter 2012 Investor Call on May 10, 2012  
5/8/2012 9:53:55 AM

ANN ARBOR, Mich., May 7, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, announces the following webcast:
//-->